Health officials are already talking about rolling out a fourth dose of the COVID-19 vaccine in the U.S. although there are still questions about the efficacy, timing, availability, and formulation of the next round of shots. Some countries like France …
It was two years ago Friday that the World Health Organization officially declared the then-rapidly spreading coronavirus outbreak a pandemic. Many of us waved goodbye to co-workers as we headed home for what was supposed to be a two- or …
President Joe Biden’s COVID-19 program faced some uncertainty Thursday, after U.S. lawmakers passed a massive new bill that would fund the federal government for the remainder of the fiscal year, as well as further aid Ukraine, but a last-minute snag …
The U.S. tally of daily cases of COVID-19 has returned to levels seen before the highly infectious omicron strain was discovered in November, helping to lower hospitalizations, the number of patients in intensive-care units and the daily death toll. The …
The Nasdaq Composite recorded its biggest percentage drop in almost two years, as well as its worst January in over a decade, despite Monday’s broader rally in stocks — capping a brutal month for investors. What happened The Nasdaq Composite …
The comments made by a Johnson & Johnson JNJ, +0.70% executive earlier this week about biotechnology valuations calls attention to the struggling biotech sector. “It’s really hard to say whether there’s been a capitulation or a recognition that values have …
On a wild Monday, the broad U.S. stock market turned green in the last few minutes of trading, recovering from big declines early in the day. As the day wore on, investors seemed to buy into the idea that the …
Not a member yet? Register now
Are you a member? Login now